State Street Corp Bristol Myers Squibb CO Transaction History
State Street Corp
- $2.36 Trillion
- Q1 2025
A detailed history of State Street Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, State Street Corp holds 94,834,478 shares of BMY stock, worth $4.55 Billion. This represents 0.24% of its overall portfolio holdings.
Number of Shares
94,834,478
Previous 95,144,745
0.33%
Holding current value
$4.55 Billion
Previous $5.38 Billion
7.48%
% of portfolio
0.24%
Previous 0.22%
Shares
21 transactions
Others Institutions Holding BMY
# of Institutions
2,748Shares Held
1.59BCall Options Held
25.8MPut Options Held
23.9M-
Vanguard Group Inc Valley Forge, PA191MShares$9.19 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.62 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.19 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.19 Billion0.83% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.6MShares$2.91 Billion0.71% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $102B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...